Nadja Prang

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

Patrick Hoffmann, Robert Hofmeister, Klaus Brischwein et al. · International Journal of Cancer · 2005 · 344 citations · Full text

Life Sciences, Immunology, Oncology +16

Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines

Nadja Prang, Susanne Preithner, Klaus Brischwein et al. · British Journal of Cancer · 2005 · 143 citations · Full text

Pharmacy, Oncology, Pharmacology +17

The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct

Christian Brandl, Cornelia Haas, Sandrine d’Argouges et al. · Cancer Immunology Immunotherapy · 2007 · 135 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Susanne Preithner, Stefanie Elm, Sandra Lippold et al. · Molecular Immunology · 2005 · 131 citations · Full text

Pharmacy, Immunology, Antibody Engineering +13

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

Bernd Schlereth, Cornelia Quadt, Torsten Dreier et al. · Cancer Immunology Immunotherapy · 2005 · 103 citations · Full text

Life Sciences, Immunology, Pathology +14